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Effects of prenatally exposed diclofenac sodium on rat heart tissue:
a stereological and histological study
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Background/aim: Diclofenac sodium (DS) can cross the placental barrier and affect the fetus, and its consumption during pregnancy
may cause developmental malformation of embryos. This study investigates the effect of prenatally applied DS on the quantitative
morphology of the adult rat heart.
Materials and methods: Pregnant rats were divided into three groups (control, sham, and test). The rats in the test group were injected
with DS; the control group received physiological saline (1 mL; 1 mg/kg, i.m.) from the 5th to the 20th day of pregnancy; and the rats in
the sham group were not injected at all. At the 20th postnatal week, all the offspring were euthanized under deep anesthesia and tissue
samples were obtained by perfusion fixation. After routine histological procedures, the paraffin sections were stained with hematoxylin
and eosin and examined stereologically and histologically.
Results: The volume of the cardiac ventricle wall of each offspring rat was estimated using Cavalieri’s principle. The volume of the
ventricle walls of the test group was found to be significantly less than that of the controls.
Conclusion: Further studies are required to determine how DS has this effect, by reducing the number of myocytes and decreasing the
size of these cells affecting the connective tissue.
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1. Introduction
Diclofenac sodium (DS) is a nonsteroidal antiinflammatory
drug (NSAID) widely used in the fields of obstetrics
and gynecology (1,2). NSAID intake during pregnancy,
however, has several negative adverse effects for both the
mother and the fetus (2). Experimental animal fetus studies
have shown that NSAID treatment causes closure of the
ductus arteriosus (DA), pulmonary arterial hypertension,
malformation (3), Purkinje cell loss in the cerebellum (4),
decreased numbers of pyramidal and granular cells in
the hippocampal formation, and suppression of new cell
formation in the spinal cords of rats (5). In addition, DS
and saline solutions impair sciatic nerve morphology (6).
In humans, maternal effects include prolonged
pregnancy and labor (7,8), while reported fetal and neonate
teratogenic effects include constriction of the DA, ischemia
of the extremities, hydrops fetalis, oligohydramnios,
ileal perforation, and cystic lesions of the brain (9–12).
Premature closure of the DA after short-term maternal
use of DS may result in severe pulmonary hypertension
* Correspondence: fikretg05@hotmail.com
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and transient right-sided hypertrophic cardiomyopathy
(3). Gastroschisis has also been observed as a possible
teratogenic effect of the administration of NSAIDs in
early pregnancy (13). As such, DS should generally not be
administered during pregnancy (14)
Except for the general work on NSAIDs previously cited,
there seems to be a lack of evidence showing that uterine
exposure to DS, in particular, increases teratogenicity,
especially of the heart (6). Thus, the effects of DS on the
development of the heart wall tissues of fetal rats were
investigated in this study. Specifically, the effects of DS
on the cardiac ventricular tissue of postnatal 20-week-old
offspring of rats treated with DS during pregnancy were
examined using stereological and histological methods.
2. Materials and methods
2.1. Animals and experimental procedures
This work was approved by the Animal Use Ethics
Commission of Yüzüncü Yil University and all procedures
were performed according to the Animal Experimentation
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Ethics Committee. Male and female adult Wistar albino
rats weighing 150–200 g were obtained from the Breeding
and Research Center for Experimental Animals of the
Yüzüncü Yıl University Faculty of Medicine, Van, Turkey,
and grouped into sham, control, and test groups. Each
group was left separately in plastic cages for mating on
the same day. The female rats were determined to be
pregnant after observing the vaginal plug produced by
male vesicular and coagulating gland secretions in the
following days (15). The pregnant rats were fed ad libitum
and kept in standard plastic cages, with sawdust bedding,
in an air-conditioned room (20 °C) under a 12/12 light/
dark cycle. Once the rats were determined to be pregnant,
DS (1 mg/kg, i.m.) was administered to the test group
on gestation days 5–20, as gestation days 9–11 represent
the critical period of organogenesis for cardiovascular
and midline development in rats, equivalent to 3–6
weeks after fertilization in human embryos (16,17). The
rats in the control group received physiological saline (1
mL/kg, i.m.), and those in the sham group received no
injected substance. All the pregnant rats were kept under
observation for 24 h on the last day of pregnancy; the day
the pups were born was deemed day zero postnatal.
Twelve offspring (six males, six females) from each
group, for a total of 36 offspring, were chosen randomly
after delivery and housed for 20 weeks. At the end of the
20th week after birth, intracardiac perfusion was performed
under anesthesia with 0.9% saline and 10% formalin on all
the rats in each group. Heart tissue samples were processed
with graded alcohol and xylene and then embedded
in paraffin blocks (18). In order to conduct successful
stereological studies, we first determined a working
strategy by conducting a pilot study and then performed
the main work. For the pilot study, whole tissue sections
(30 µm) were taken transversely from the beginning to the
end of one paraffin block with a rotary microtome (Leica
RM 2135; Leica Instruments, Germany), and stained with
hematoxylin and eosin. Each animal had an average of
12 sections from which a systematic random sampling of
slices was taken and stereological and histological analyses
were performed.
2.2. Stereological and histological analysis
All of the microscopic examinations for the stereological
and histological analyses were performed using a stereo
investigator system, which included stereological analysis
software (Stereo Investigator; MBF Biosciences, USA)
and hardware. Certain processes can be performed easily
with this analyzing system, such as determination of
tissue boundaries and area, random sampling area, and
step-by-step scanning. In order to calculate the volume
of the cardiac ventricular wall using the Cavalieri method
(19,20), the cross-sections, prepared as determined by
the pilot study, were examined under a light microscope.

An image of the heart was shown on the screen, and the
area to be measured was marked by a line via software
under lens 5 of the microscope. After circling the point of
measurement, a table was placed on display via software.
The space of one point of the point area measurement
table (a/p) was calculated as 360,000 µm2 automatically by
the system inputting x- and y-axis values of 600 µm. We
analyzed the whole tissue on the cross-sections outside the
systematic random sampling area, thereby counting the
points falling on the image of the cardiac ventricular tissue
on all the sections of each animal examined. Subsequently
we calculated the total volume of the heart ventricular wall
with the following formula:
[V = a/p∙∑n(i = 1)Pi (SSR)∙(ASR)∙t ], where a/p is the unit area
represented by one point, ∑ Pi is the total number of points
counted from the sections of one animal, SSR is the slice
sample rate (1/22), ASR is the area sampling rate (1/1), and
t- is the average cross-sectional thickness. Slice thicknesses
in the image areas, determined as systematically random
by using all five steps, were measured with a microcator.
For test result reliability and impartiality, all data were
obtained through the blind study encoding method.
2.3. Statistical analysis
The statistical analyses for this study were performed using
SPSS 13.0 for Windows. Evaluation of the results among
the groups was performed using a one-way ANOVA test.
A t-test was used to compare the average wall volumes of
male and female rats.
3. Results
3.1. Stereological results
After obtaining the data from the stereological findings, the
volumes of the rats’ heart ventricle walls were calculated
separately for males and females. The error coefficients of
our stereological studies for ∑ Pi (total points) were found
to be acceptable (CE ≤ 0.05), as shown in the Table. The
average volumes of the cardiac ventricular walls of all the
groups were calculated as follows: for females, control:
269.14 mm3, sham: 268.14 mm3, and test: 204.89 mm3; and
for males, control: 412.97 mm3, sham: 408.40 mm3, and
test: 328.44 mm3 (Table; Figures 1–3).
These values were compared with the ANOVA statistical
test, and a significant difference was found between the
males and females according to groups (P < 0.01; Figure
3). There were no differences between the sham and
control groups in both sexes, but there were statistically
significant differences between the test group and the two
control groups (sham and control) (P < 0.05), as shown in
Figures 1 and 2. To compare the males and females, a t-test
was carried out, and a significant difference was observed
between their mean cardiac ventricular wall volumes (P <
0.01). In all three groups, the wall volumes of the male and
female rats were different (P < 0.01; Figure 3). The volumes
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Table. Data used in the calculation of cardiac ventricular wall volume and calculated average heart
ventricle wall volume (V) with intragroup coefficients of variation (CV), standard deviations (SD),
coefficient of error (CE), and standard error of mean (SEM) values. : average total point, NS: average
number of slices, : average cross-sectional thickness; n: number of rats.
Males
Sham

Test

Control

Sham

Test

1956

1929

1550

1296

1278

989

NS

14

15

14

12

13

12

CE

0.020

0.023

0.025

0.014

0.017

0.019

(µm)

26.20

26.48

26.14

26.63

26.72

26.74

V (mm³)

269.14

268.14

204.89

412.97

408.40

328.44

CV

0.033

0.043

0.045

0.055

0.031

0.052

SD

8.901

11.632

9.265

23.045

12.689

17.148

SEM

3.633

4.749

3.782

9.408

5.180

7.00

n

6

6

6

6

6

6

400

Male

250

350

100
Control

Sham

Test

Figure 1. Average volume of heart ventricular wall in each group
of female rats (*: P < 0.05).
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Figure 3. Average volume values for both sexes by group and
total mean (**: P < 0.01).
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Figure 2. Average volume of heart ventricular wall in each group
of male rats (*: P < 0.05).
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of the heart ventricular walls of both the male and female
test groups were significantly lower compared to those of
the sham and control groups. This reduced volume in the
test group was approximately 20.5% for males and 23.8%
for females.
3.2. Histological results
In addition to stereological analysis, the cardiac
ventricular tissues were examined under light microscopy
for any histological changes in the tissues on thin crosssections (5 µm) stained with hematoxylin and eosin. The
tissue sections of all the offspring were compared among
the three groups (test, sham, and control). Microscopic
analysis revealed normal cardiac ventricular muscle tissue
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in all three groups; that is, the cardiac ventricular muscle
tissues all had a centrally located nucleus. Intracellular
contractile myofilament (understood striating) branching
and anastomosing striated heart muscle cells were
observed. However, in some sections, the heart ventricle
muscle tissues of the test group had more extracellular
matrix and weaker muscle fibers than did those of the
sham and control groups, in both males and females. In
addition, the heart muscle cells of the females were thinner
than those of the males (Figures 4 and 5). A more detailed
histopathological study is needed for a final judgment on
this issue.
4. Discussion
DS is a member of the NSAID group and is sometimes used
during pregnancy in cases of necessity or unawareness of
pregnancy, which may have adverse side effects on the
developing fetal organs. For this reason, we investigated
the effects of DS on the heart ventricle tissues of 20-weekold rats that were exposed to this drug in utero. We found
that this drug caused a decrease in the volume of the heart

ventricle wall in experimental rats of both sexes.
NSAIDs are widely consumed as analgesics,
antipyretics, and antiinflammatories, especially in physical
therapy (2,21). Most studies associated with the treatment
of rheumatoid arthritis have focused on NSAIDs such
as aspirin (acetylsalicylic acid) and indomethacin. The
literature is rather sparse regarding the consumption of
other NSAIDs, such as ibuprofen, sulindac, ketoprofen,
fenamates, oxicams, and diclofenac, during pregnancy.
NSAIDs should generally not be administered in early
pregnancy, though their use might be advised in some
circumstances, such as preeclampsia. In addition, DS is
used widely for women of childbearing age to relieve a
variety of conditions, including common gynecological
problems; although pregnancy is often planned nowadays,
pregnant women might still accidentally use NSAIDs such
as DS during different stages of gestation (14). There is no
absolute proof relating to the teratogenic effects of NSAIDs
on the heart (8,22). Because DS is used in the treatment
of certain problems observed in pregnancy, such as
premature birth and preeclampsia, research is necessary in

A

B

C
Figure 4. Male rats’ heart ventricle tissue. A) Sham, B) control, C) test group. As seen in the pictures, test tissue had more space between
myocytes and weak muscle fibers compared to other groups (H&E, 40× obj.).
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A

B

C
Figure 5. Female rats’ heart ventricle tissue. A) Sham, B) control, C) test group. As seen in the pictures, test tissue had more space
between myocytes and weak muscle fibers compared to other groups (H&E, 40× obj.).

order to determine its possible teratogenic effects (23,24).
Among the common features of NSAIDs are their
prevention of several mechanisms, such as phospholipase
C enzyme activation, ion transport, mitochondrial
oxidative phosphorylation, and cell interaction (2,23).
They also inhibit the cyclooxygenase enzyme, which
catalyzes the formation of prostaglandin and some
prostanoids from arachidonic acid in tissues (2,25). All
NSAIDs are thus prostaglandin inhibitors, which explains
their fetal toxicity, as prostaglandins produced in many
tissues and membranes have very important roles in
fetal development (2,26,27). NSAIDs inhibit prostanoid
biosynthesis and cross the placental barrier by joining the
fetal circulation, upon which they cause teratogenic effects
in the fetus (2,12,28).
DS also has some important, specific, and adverse
effects on the DA, the most important being the contraction
of the fetal DA (29). Arachidonic acid metabolites can
be highly concentrated in fetal blood circulation; they
regulate umbilical cord blood circulation and enable the
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DA to remain open during fetal life (30). In uterine life,
deoxygenated blood flows away from the pulmonary
artery and goes to the fetal placental circulation, where
gas exchange occurs (31). As a result of their complex
biochemical and physiological entanglement, these vessels
quickly contract and constrict after birth; the direction of
deoxygenated blood flow thus changes from the placenta
to the lungs for gas exchange. Premature closure of the
DA may cause pulmonary hypertension and even death in
utero (32,33).
Closed approximately 10–15 h after birth, the DA must
remain open for fetal tissue oxygenation throughout fetal
life (13). Contraction and shrinkage of the DA is inevitable
as a result of treatment with cyclooxygenase inhibitors to
prevent premature birth (10,12,34). DA contraction may
lead to an increase in pulmonary vascular resistance,
and, thus, right ventricular dilatation and tricuspid valve
insufficiency may occur in the heart. Right ventricular
failure leads to hyperemia and stasis, which affects the
liver, spleen, kidney, and brain tissues, causing congestion
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of these organs (33). Right ventricular failure, prominent
in congestive heart failure, leads to congestion of the liver;
therefore, developing liver stasis may result in dilatation of
the sinusoids, hepatocyte degeneration, and even the death
of parenchymal cells (35). It has also been observed that
administration of NSAIDs to pregnant rats on gestation
days 9–10 reduced maternal body weight and feed
consumption, fetal weight, and increased ventricular septal
defects (17). Logically, the results of our study support
these findings. As mentioned, the most pronounced effect
of DS is contraction of the fetal DA, which may result in
negative events such as escape back to the tricuspid, rightsided ventricular heart failure, and shunting between the
atriums in the heart. Eventually, a reduction in the amount
of systemic blood reaching the liver tissues in particular
may result, leading to a number of likely degenerations in
the parenchymal cells of these tissues. Our study indicates
that a reduction in cardiac ventricular wall volume and the
histological changes observed in the cardiac ventricular
muscle are not directly due to the contraction of DA. They
may be the combined effects of DS and its metabolites and
the side effects of DS-deregulated umbilical cord blood
circulation (36).
Two different examinations were made of the 20-weekold rats, which were exposed to the same DS doses during
the same period and days of uterine life. The total number
of Purkinje cells in the cerebellum was calculated using
stereological methods, and the differences between the
control and test groups were determined (4). The results
showed that this drug decreases the number of cells.
Similar results of the side effects of prenatal exposure to
DS on the central and peripheral nervous tissues were also
found by our group (4–6). On the other hand, even prenatal
exposure of DS increased total Purkinje cell number in the
female rats (37), but no significant differences were found
between the granular cell numbers of male juvenile and
adult rats exposed to DS prenatally (38). These results
may be sex-dependent and require a detailed explanation.

Besides the investigation of the nervous tissue, we also
examined the lung tissues of the rats exposed prenatally to
DS, and no histological difference was observed between
the control and test groups (39).
As understood from the detailed description here,
prenatal exposure to DS can cause a number of challenges
in fetal tissues. Our present study results indicate that
DS causes a decrease in the cardiac ventricular wall mass
of 20-week-old rats exposed to DS in utero. All of these
findings point to the importance of avoiding DS during
pregnancy, regardless of the recommended dose (14).
While the possibility of treatment with antirheumatic
drugs in pregnancy has become inevitable, NSAIDs should
be considered in terms of the teratogenic risks to human
embryos.
We observed significantly reduced cardiac ventricle wall
volume in 20-week-old offspring rats prenatally exposed
to DS (1 mg kg–1 day–1) for 15 days, from gestational days
5 to 20, which is the critical period of organogenesis in the
rat, equivalent to 3–6 weeks after fertilization in human
embryos (16). However, in this study, no significant
histological changes were found between the controls and
the test group. How the volume of the heart ventricular
wall decreases with administration of DS is not fully
understood. Further studies should investigate how the
effect of DS on the heart tissue occurs, by reducing the
number of myocytes, decreasing the size of the cells, or
affecting connective tissue between the cells. Considering
all of these complications, women should refrain from
taking DS, especially during pregnancy.
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